Related Experiment Video
Updated: Aug 12, 2026

11:50
Ex vivo Mimicry of Normal and Abnormal Human Hematopoiesis
Published on: April 10, 2012
Observations on the haemopoietic response to critical illness
R J Amos1, M Deane, C Ferguson
1Department of Haematology, St Bartholomew's Hospital, West Smithfield, London.
Journal of Clinical Pathology
|October 1, 1990
Summary
Intensive care patients often develop low blood cell counts due to bone marrow issues. Bone marrow hypoplasia, characterized by reduced cellularity and abnormal architecture, significantly impairs hematopoietic progenitor cell growth.
Area of Science:
- Hematology
- Critical Care Medicine
- Pathology
Background:
- Peripheral blood cytopenias are frequent in intensive care unit (ICU) patients, especially those with multiple organ failure.
- Bone marrow hypoplasia is a suspected contributor to these cytopenias.
- Understanding bone marrow changes is crucial for managing ICU-related hematological complications.
Purpose of the Study:
- To investigate the role of bone marrow hypoplasia in intensive care patients with cytopenias.
- To characterize morphological and functional bone marrow abnormalities in this patient cohort.
- To correlate bone marrow findings with hematopoietic progenitor cell function.
Main Methods:
- Analysis of 44 bone marrow samples from 24 intensive care patients using standard morphological techniques.
- Assessment of granulocyte-macrophage colony-forming cell (GM-CFC) growth.
- Sequential studies in a subset of patients to track changes over time.
Main Results:
- Observed abnormalities included reduced bone marrow cellularity, increased phagocytic macrophages, and disrupted architecture with hyaluronic acid accumulation.
- Mean GM-CFC growth was significantly reduced compared to normal controls.
- Sequential studies showed declining GM-CFC growth associated with reduced cellularity.
Conclusions:
- Morphological changes in the bone marrow of ICU patients resemble gelatinous degeneration.
- Disruption of the hematopoietic microenvironment, including hyaluronic acid accumulation, likely inhibits progenitor cell growth.
- Macrophage proliferation and associated factors may also contribute to impaired hematopoiesis.
Related Concept Videos
Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Overview of Hematopoiesis
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
Factors Affecting Erythropoiesis
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...

